Original ArticlesComparison of Methods of Initial Ascertainment in 58 Cases of Propionic Acidemia Enrolled in the Inborn Errors of Metabolism Information System Reveals Significant Differences in Time to Evaluation and Symptoms at Presentation
Section snippets
Methods
We reviewed available data for 61 patients with PA enrolled in the IBEM-IS. Three patients with no information on initial presentation were excluded. The data review was retrospective and included data entered between June 13, 2007, and November 6, 2015. The abstracted data did not include direct or indirect identifiers. This study was reviewed and granted exempt status by the Institutional Review Board for Clinical Investigations at Duke University and at the University of Wisconsin at Madison.
Results
Data for 58 patients with PA entered into the IBEM-IS were evaluated. The dataset represents a fairly balanced distribution with respect to sex (females, n = 26; males, n = 32). The majority of patients were Caucasian (44 of 58), 3 were Black/African American, 1 was American Indian, and 3 were reported as mixed race. Seven patients lacked information regarding race. Seven individuals were also identified as Amish.
Discussion
We analyzed initial presentations in a cohort of 58 patients with PA enrolled in the IBEM-IS and compared initial symptoms and time to evaluation based on 3 methods of ascertainment reported by the originating center (abnormal NBS, clinical presentation, and family history). The IBEM-IS captures age at initial evaluation by a metabolic specialist and institution of treatment, but not age at presentation. Previous studies have reported that the vast majority of patients with PA present during
References (19)
- et al.
Propionic acidemia mimicking diabetic ketoacidosis
Brain Dev
(2011) - et al.
Propionic acidemia: case report and review of neurologic sequelae
Pediatr Neurol
(2009) - et al.
Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters
Biochim Biophys Acta
(2014) - et al.
High frequency of large genomic deletions in the PCCA gene causing propionic acidemia
Mol Genet Metab
(2009) - et al.
Inherited propionyl-Coa carboxylase deficiency in “ketotic hyperglycinemia”
J Clin Invest
(1971) - et al.
Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes
Proc Natl Acad Sci U S A
(1986) - et al.
Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey
J Pediatr
(2002) - et al.
Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany
Pediatrics
(2002) - et al.
A new era for preventive genetic programs in the Arabian Peninsula
Saudi Med J
(2003)
Cited by (14)
Long-term outcomes in Amish patients diagnosed with propionic acidemia
2018, Molecular Genetics and Metabolism ReportsCitation Excerpt :Long term neurologic outcomes may be better with knowledge of the disorder and education for illness care. Prior reports described cardiomyopathy in PA patients as a presenting sign or symptom, lethal complications of acute decompensation, or as chronic complication of the disorder [4–6,11–14]. Of the twenty patients, 5 experienced cardiomyopathy or cardiac related sudden death regardless of the method for diagnosis.
Newborn screening for proximal urea cycle disorders: Current evidence supporting recommendations for newborn screening
2018, Molecular Genetics and MetabolismCitation Excerpt :Data has shown that the proximal UCD present at ≤2 days in 55% and at <7 days 84% of OTC/CPS patients and have a higher peak ammonia level and a longer average length of stay when compared to patients with distal UCD [7]. This criticism should be considered in light of other current RUSP disorders with “early-onset” presentations such as the distal UCD (e.g., CIT1, ASA) and other “role model” disorders like isolated methylmalonic acidemia and propionic acidemia [20–22]. The improved outcomes of other “early onset” disorders support the potential impact of NBS for the early onset of symptoms in proximal UCD.
Propionyl-CoA carboxylase – A review
2017, Molecular Genetics and MetabolismCitation Excerpt :Individuals with classical PA are usually asymptomatic at birth, but present in the first few hours to days of life due to symptoms of metabolic decompensation including poor feeding, vomiting, hyper- or hypotonia, temperature instability, irritability, and lethargy [90–92]. Laboratory abnormalities at presentation may reveal severe, persistent wide anion gap metabolic acidosis with ketosis, hyperlactatemia and hyperammonemia [90,91,93]. Since the clinical presentations of PA individuals are non-specific, mistreatment or inadequate treatment cause deterioration of metabolic decompensation and, if left untreated, lead to death.
Dietary practices in propionic acidemia: A European survey
2017, Molecular Genetics and Metabolism ReportsCitation Excerpt :In our cohort, 31/38 centres had a median total protein ingested (natural protein plus PFAA) above 120% of WHO/FAO/UNU safe levels of protein intake in at least one age range [6]. Excess PFAA will provide an additional nitrogen load which may contribute to hyperammonaemia, a complication commonly reported in PA [25,26], associated with N-acetylglutamate synthetase inactivation due to accumulation of propionyl CoA [27]. PFAA designed for PA (without valine, methionine, threonine and isoleucine) contain normal to increased amounts of leucine (e.g. 158 mg of leucine per g of protein equivalent from PFAA vs. approximately 100 mg of leucine per 1 g of protein from egg).
Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns
2022, Journal of Pediatric Endocrinology and Metabolism
Funding information is available at www.jpeds.com (Appendix 2). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest.
- *
A list of additional members of the Inborn Errors of Metabolism Collaborative is available at www.jpeds.com (Appendix 1).